Cargando…
Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model
Multiple myeloma is a malignant still incurable plasma cell disorder. This is due to refractory disease relapse, immune impairment, and development of multi-drug resistance. The growth of malignant plasma cells is dependent on the bone marrow (BM) microenvironment and evasion of the host's anti...
Autores principales: | Ji, Zhiwei, Su, Jing, Wu, Dan, Peng, Huiming, Zhao, Weiling, Zhao, Brian Nlong, Zhou, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352350/ https://www.ncbi.nlm.nih.gov/pubmed/28032590 http://dx.doi.org/10.18632/oncotarget.13831 |
Ejemplares similares
-
Systemic modeling myeloma-osteoclast interactions under normoxic/hypoxic condition using a novel computational approach
por: Ji, Zhiwei, et al.
Publicado: (2015) -
Identification of cancer prognosis-associated functional modules using differential co-expression networks
por: Yu, Wenshuai, et al.
Publicado: (2017) -
Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts
por: Qiao, Minna, et al.
Publicado: (2015) -
Prediction of treatment efficacy for prostate cancer using a mathematical model
por: Peng, Huiming, et al.
Publicado: (2016) -
The role of SH3GL3 in myeloma cell migration/invasion, stemness and chemo-resistance
por: Chen, Ruoying, et al.
Publicado: (2016)